Data for Regeneron arthritis drug in coronavirus could come in weeks
Regeneron could release data within weeks about how well its arthritis drug Kevzara is battling the new coronavirus, its chief scientific officer said during a STAT video chat Wednesday.
George Yancopolous, who is also the Tarrytown, N.Y.-based biotech’s co-founder, made it clear during the chat that the battle, for him, is personal.
Read Original Article: Data for Regeneron arthritis drug in coronavirus could come in weeks »
